1. Home
  2. GKOS vs OGCP Comparison

GKOS vs OGCP Comparison

Compare GKOS & OGCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • OGCP
  • Stock Information
  • Founded
  • GKOS 1998
  • OGCP N/A
  • Country
  • GKOS United States
  • OGCP
  • Employees
  • GKOS N/A
  • OGCP 667
  • Industry
  • GKOS Medical/Dental Instruments
  • OGCP
  • Sector
  • GKOS Health Care
  • OGCP
  • Exchange
  • GKOS Nasdaq
  • OGCP NYSE
  • Market Cap
  • GKOS 5.1B
  • OGCP N/A
  • IPO Year
  • GKOS 2015
  • OGCP N/A
  • Fundamental
  • Price
  • GKOS $93.79
  • OGCP $6.92
  • Analyst Decision
  • GKOS Strong Buy
  • OGCP
  • Analyst Count
  • GKOS 13
  • OGCP 0
  • Target Price
  • GKOS $155.00
  • OGCP N/A
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • OGCP N/A
  • Earning Date
  • GKOS 04-30-2025
  • OGCP N/A
  • Dividend Yield
  • GKOS N/A
  • OGCP N/A
  • EPS Growth
  • GKOS N/A
  • OGCP N/A
  • EPS
  • GKOS N/A
  • OGCP N/A
  • Revenue
  • GKOS $383,481,000.00
  • OGCP N/A
  • Revenue This Year
  • GKOS $27.84
  • OGCP N/A
  • Revenue Next Year
  • GKOS $27.99
  • OGCP N/A
  • P/E Ratio
  • GKOS N/A
  • OGCP N/A
  • Revenue Growth
  • GKOS 21.85
  • OGCP N/A
  • 52 Week Low
  • GKOS $77.91
  • OGCP N/A
  • 52 Week High
  • GKOS $163.71
  • OGCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 46.82
  • OGCP 36.60
  • Support Level
  • GKOS $92.79
  • OGCP $8.08
  • Resistance Level
  • GKOS $97.38
  • OGCP $7.08
  • Average True Range (ATR)
  • GKOS 4.43
  • OGCP 0.08
  • MACD
  • GKOS 1.61
  • OGCP 0.08
  • Stochastic Oscillator
  • GKOS 72.39
  • OGCP 80.72

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About OGCP EMPIRE STATE REALTY OP LIM PARTNER

Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.

Share on Social Networks: